Showing 91-100 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Prevalence of Endogenous Hypercortisolism in People with poorly controlled Type 1 Diabetes: Hypercortisolism In Type 1 DM (HIT-T1D) | Tulane University | Vivian Fonseca | Improving Lives | 01-October-2026 to 30-September-2029 | $2.309.103,00 |
| Engineering regulatory B cells to promote immune tolerance for islet cell replacement therapy: A novel opportunity to cure Type I diabetes | Trustees of the University of Pennsylvania | James Markmann | Cures | 01-October-2026 to 30-September-2029 | $598.995,17 |
| Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs | Trustees of the University of Pennsylvania | Ji Lei | Cures | 01-June-2025 to 31-May-2027 | $749.999,08 |
| A bioelectronics platform to standardize SC-islet maturation and model T1D autoimmunity | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-October-2026 to 30-September-2029 | $1.049.999,94 |
| An AI-driven bioelectronics system to accelerate SC-islet maturation | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-April-2025 to 01-March-2027 | $200.000,00 |
| Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-September-2024 to 31-August-2027 | $900.000,00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 31-December-2026 | $560.000,00 |
| β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes | Trustees of Indiana University | Carmella Evans-Molina | Cures | 01-March-2026 to 28-February-2029 | $748.179,00 |
| Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes | Trustees of Indiana University | Chaitra Rao | Cures | 01-March-2024 to 30-April-2027 | $215.972,69 |
| Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population | Trustees of Indiana University | Emily Sims | Cures | 01-February-2026 to 31-January-2029 | $691.694,00 |